GABA and glutamate pathways are spatially and developmentally affected in the brain of Mecp2-deficient mice

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  El Khoury, Rita ^a,b   Panayotis, Nicolas ^a,b,c   Matagne, Valérie ^a,b   Ghata, Adeline ^a,b   Villard, Laurent ^a,b   Roux, Jean Christophe ^a,b  

^a AIX MARSEILLE UNIVERSITY   (France)

^b INSERM   (France)

^c WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; GLUTAMIC ACID; MESSENGER RNA; METHYL CPG BINDING PROTEIN 2; TIAGABINE; 4 AMINOBUTYRIC ACID RECEPTOR STIMULATING AGENT; MECP2 PROTEIN, MOUSE; NIPECOTIC ACID DERIVATIVE;

AMINO ACID BLOOD LEVEL; AMINO ACID METABOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN STEM; CAUDATE NUCLEUS; CEREBELLUM; CONTROLLED STUDY; FLUORESCENCE; GABAERGIC SYSTEM; GENE DELETION; GENE EXPRESSION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIPPOCAMPUS; HYPOTHALAMUS; IN VIVO STUDY; LIFESPAN; MALE; MOTOR CORTEX; MOUSE; NEUROTRANSMISSION; NONHUMAN; PROTEIN EXPRESSION; PUTAMEN; RETT SYNDROME; SIGNAL TRANSDUCTION; SPINAL CORD; SUBSTANTIA NIGRA PARS RETICULATA; ANIMAL; BRAIN; C57BL MOUSE; CELL CULTURE; CHEMISTRY; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SYNAPTIC TRANSMISSION; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; BRAIN; CELLS, CULTURED; GABA AGONISTS; GAMMA-AMINOBUTYRIC ACID; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GLUTAMIC ACID; MALE; METHYL-CPG-BINDING PROTEIN 2; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NIPECOTIC ACIDS; REAL-TIME POLYMERASE CHAIN REACTION; RETT SYNDROME; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; SYNAPTIC TRANSMISSION;

EID: 84899790784     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0092169     Document Type: Article

References (73)

1. Mel BW, Schiller J (2004) On the fight between excitation and inhibition: location is everything. Sci STKE 2004: PE44.
2. Cossart R, Bernard C, Ben-Ari Y (2005) Multiple facets of GABAergic neurons and synapses: multiple fates of GABA signalling in epilepsies. Trends Neurosci 28: 108-115. (Pubitemid 40178928)
3. Lewis DA, Curley AA, Glausier JR, Volk DW (2012) Cortical parvalbumin interneurons and cognitive dysfunction in schizophrenia. Trends Neurosci 35: 57-67.
4. Lerner A, Bagic A, Simmons JM, Mari Z, Bonne O, et al. (2012) Widespread abnormality of the gamma-aminobutyric acid-ergic system in Tourette syndrome. Brain 135: 1926-1936.
5. Guy J, Cheval H, Selfridge J, Bird A (2011) The role of MeCP2 in the brain. Annu Rev Cell Dev Biol 27: 631-652.
6. Guerrini R, Parrini E (2012) Epilepsy in Rett syndrome, and CDKL5- and FOXG1-gene-related encephalopathies. Epilepsia 53: 2067-2078.
7. Ide S, Itoh M, Goto Y (2005) Defect in normal developmental increase of the brain biogenic amine concentrations in the mecp2-null mouse. Neurosci Lett 386: 14-17. (Pubitemid 41019635)
8. Lang M, Wither RG, Brotchie JM, Wu C, Zhang L, et al. (2013) Selective preservation of MeCP2 in catecholaminergic cells is sufficient to improve the behavioral phenotype of male and female Mecp2-deficient mice. Hum Mol Genet 22: 358-371.
9. Panayotis N, Ghata A, Villard L, Roux JC (2011) Biogenic amines and their metabolites are differentially affected in the Mecp2-deficient mouse brain. BMC Neurosci 12: 47.
10. Panayotis N, Pratte M, Borges-Correia A, Ghata A, Villard L, et al. (2011) Morphological and functional alterations in the substantia nigra pars compacta of the Mecp2-null mouse. Neurobiol Dis 41: 385-397.
11. Roux JC, Panayotis N, Dura E, Villard L (2010) Progressive noradrenergic deficits in the locus coeruleus of Mecp2 deficient mice. J Neurosci Res 88: 1500-1509.
12. Roux JC, Villard L (2010) Biogenic amines in Rett syndrome: the usual suspects. Behav Genet 40: 59-75.
13. Samaco RC, Mandel-Brehm C, Chao HT, Ward CS, Fyffe-Maricich SL, et al. (2009) Loss of MeCP2 in aminergic neurons causes cell-autonomous defects in neurotransmitter synthesis and specific behavioral abnormalities. Proc Natl Acad Sci U S A 106: 21966-21971.
14. Santos M, Summavielle T, Teixeira-Castro A, Silva-Fernandes A, Duarte-Silva S, et al. (2010) Monoamine deficits in the brain of methyl-CpG binding protein 2 null mice suggest the involvement of the cerebral cortex in early stages of Rett syndrome. Neuroscience 170: 453-467.
15. Viemari JC, Roux JC, Tryba AK, Saywell V, Burnet H, et al. (2005) Mecp2 deficiency disrupts norepinephrine and respiratory systems in mice. J Neurosci 25: 11521-11530. (Pubitemid 43098445)
16. Calfa G, Hablitz JJ, Pozzo-Miller L (2011) Network hyperexcitability in hippocampal slices from Mecp2 mutant mice revealed by voltage-sensitive dye imaging. J Neurophysiol 105: 1768-1784.
17. Chao HT, Zoghbi HY, Rosenmund C (2007) MeCP2 controls excitatory synaptic strength by regulating glutamatergic synapse number. Neuron 56: 58-65. (Pubitemid 47484176)
18. Dani VS, Chang Q, Maffei A, Turrigiano GG, Jaenisch R, et al. (2005) Reduced cortical activity due to a shift in the balance between excitation and inhibition in a mouse model of Rett syndrome. Proc Natl Acad Sci U S A 102: 12560-12565. (Pubitemid 41266398)
19. Dani VS, Nelson SB (2009) Intact long-term potentiation but reduced connectivity between neocortical layer 5 pyramidal neurons in a mouse model of Rett syndrome. J Neurosci 29: 11263-11270.
20. Zhang ZW, Zak JD, Liu H (2010) MeCP2 is required for normal development of GABAergic circuits in the thalamus. J Neurophysiol 103: 2470-2481.
21. Kline DD, Ogier M, Kunze DL, Katz DM (2010) Exogenous brain-derived neurotrophic factor rescues synaptic dysfunction in Mecp2-null mice. J Neurosci 30: 5303-5310.
22. Medrihan L, Tantalaki E, Aramuni G, Sargsyan V, Dudanova I, et al. (2008) Early defects of GABAergic synapses in the brain stem of a MeCP2 mouse model of Rett syndrome. J Neurophysiol 99: 112-121.
23. Stettner GM, Huppke P, Brendel C, Richter DW, Gartner J, et al. (2007) Breathing dysfunctions associated with impaired control of postinspiratory activity in Mecp2-/y knockout mice. J Physiol 579: 863-876. (Pubitemid 46404365)
24. Taneja P, Ogier M, Brooks-Harris G, Schmid DA, Katz DM, et al. (2009) Pathophysiology of locus ceruleus neurons in a mouse model of Rett syndrome. J Neurosci 29: 12187-12195.
25. Abdala AP, Dutschmann M, Bissonnette JM, Paton JF (2010) Correction of respiratory disorders in a mouse model of Rett syndrome. Proc Natl Acad Sci U S A 107: 18208-18213.
26. Fischer M, Reuter J, Gerich FJ, Hildebrandt B, Hagele S, et al. (2009) Enhanced hypoxia susceptibility in hippocampal slices from a mouse model of rett syndrome. J Neurophysiol 101: 1016-1032.
27. Moretti P, Levenson JM, Battaglia F, Atkinson R, Teague R, et al. (2006) Learning and memory and synaptic plasticity are impaired in a mouse model of Rett syndrome. J Neurosci 26: 319-327. (Pubitemid 43089545)
28. Nelson ED, Bal M, Kavalali ET, Monteggia LM (2011) Selective impact of MeCP2 and associated histone deacetylases on the dynamics of evoked excitatory neurotransmission. J Neurophysiol 106: 193-201.
29. Zhang L, He J, Jugloff DG, Eubanks JH (2008) The MeCP2-null mouse hippocampus displays altered basal inhibitory rhythms and is prone to hyperexcitability. Hippocampus 18: 294-309. (Pubitemid 351399632)
30. Wood L, Gray NW, Zhou Z, Greenberg ME, Shepherd GM (2009) Synaptic circuit abnormalities of motor-frontal layer 2/3 pyramidal neurons in an RNA interference model of methyl-CpG-binding protein 2 deficiency. J Neurosci 29: 12440-12448.
31. Wood L, Shepherd GM (2010) Synaptic circuit abnormalities of motor-frontal layer 2/3 pyramidal neurons in a mutant mouse model of Rett syndrome. Neurobiol Dis 38: 281-287.
32. Kron M, Howell CJ, Adams IT, Ransbottom M, Christian D, et al. (2012) Brain activity mapping in Mecp2 mutant mice reveals functional deficits in forebrain circuits, including key nodes in the default mode network, that are reversed with ketamine treatment. J Neurosci 32: 13860-13872.
33. Guy J, Hendrich B, Holmes M, Martin JE, Bird A (2001) A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome. Nat Genet 27: 322-326. (Pubitemid 32201856)
34. Roux JC, Dura E, Villard L (2008) Tyrosine hydroxylase deficit in the chemoafferent and the sympathoadrenergic pathways of the Mecp2 deficient mouse. Neurosci Lett 447: 82-86.
35. Ricceri L, De Filippis B, Laviola G (2008) Mouse models of Rett syndrome: from behavioural phenotyping to preclinical evaluation of new therapeutic approaches. Behav Pharmacol 19: 501-517.
36. Pratte M, Panayotis N, Ghata A, Villard L, Roux JC (2011) Progressive motor and respiratory metabolism deficits in post-weaning Mecp2-null male mice. Behav Brain Res 216: 313-320.
37. Palkovits N, Brownstein MJ (1988) Maps and guide to microdissection of rat brain. Elsevier, New York-Amsterdam-London.
38. Paxinos G, Franklin K (2001) The mouse brain in stereotaxic coordinates. . Academic, Sandiego.
39. Roux JC, Mamet J, Perrin D, Peyronnet J, Royer C, et al. (2003) Neurochemical development of the brainstem catecholaminergic cell groups in rat. J Neural Transm 110: 51-65. (Pubitemid 36135554)
40. Sauvinet V, Parrot S, Benturquia N, Bravo-Moraton E, Renaud B, et al. (2003) In vivo simultaneous monitoring of gamma-aminobutyric acid, glutamate, and L-aspartate using brain microdialysis and capillary electrophoresis with laser-induced fluorescence detection: Analytical developments and in vitro/in vivo validations. Electrophoresis 24: 3187-3196. (Pubitemid 38094247)
41. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408. (Pubitemid 34164012)
42. Coenen AM, Blezer EH, van Luijtelaar EL (1995) Effects of the GABA-uptake inhibitor tiagabine on electroencephalogram, spike-wave discharges and behaviour of rats. Epilepsy Res 21: 89-94.
43. Thoeringer CK, Erhardt A, Sillaber I, Mueller MB, Ohl F, et al. (2010) Long-term anxiolytic and antidepressant-like behavioural effects of tiagabine, a selective GABA transporter-1 (GAT-1) inhibitor, coincide with a decrease in HPA system activity in C57BL/6 mice. J Psychopharmacol 24: 733-743.
44. McDonald LM, Sheppard WF, Staveley SM, Sohal B, Tattersall FD, et al. (2008) Discriminative stimulus effects of tiagabine and related GABAergic drugs in rats. Psychopharmacology (Berl) 197: 591-600.
45. Roux JC, Zala D, Panayotis N, Borges-Correia A, Saudou F, et al. (2012) Modification of Mecp2 dosage alters axonal transport through the Huntingtin/Hap1 pathway. Neurobiol Dis 45: 786-795.
46. Ben-Ari Y, Khalilov I, Kahle KT, Cherubini E (2012) The GABA excitatory/inhibitory shift in brain maturation and neurological disorders. Neuroscientist 18: 467-486.
47. Chahrour M, Zoghbi HY (2007) The story of Rett syndrome: from clinic to neurobiology. Neuron 56: 422-437. (Pubitemid 350026269)
48. Rowley NM, Madsen KK, Schousboe A, Steve White H (2012) Glutamate and GABA synthesis, release, transport and metabolism as targets for seizure control. Neurochem Int 61: 546-558.
49. Stanley BG, Urstadt KR, Charles JR, Kee T (2011) Glutamate and GABA in lateral hypothalamic mechanisms controlling food intake. Physiol Behav 104: 40-46.
50. Akbarian S, Chen RZ, Gribnau J, Rasmussen TP, Fong H, et al. (2001) Expression pattern of the Rett syndrome gene MeCP2 in primate prefrontal cortex. Neurobiol Dis 8: 784-791. (Pubitemid 33055595)
51. Chao HT, Chen H, Samaco RC, Xue M, Chahrour M, et al. (2010) Dysfunction in GABA signalling mediates autism-like stereotypies and Rett syndrome phenotypes. Nature 468: 263-269.
52. Viola A, Saywell V, Villard L, Cozzone PJ, Lutz NW (2007) Metabolic fingerprints of altered brain growth, osmoregulation and neurotransmission in a Rett syndrome model. PLoS One 2: e157.
53. Chang YC, Gottlieb DI (1988) Characterization of the proteins purified with monoclonal antibodies to glutamic acid decarboxylase. J Neurosci 8: 2123-2130.
54. Obata K, Fukuda T, Konishi S, Ji FY, Mitoma H, et al. (1999) Synaptic localization of the 67,000 mol. wt isoform of glutamate decarboxylase and transmitter function of GABA in the mouse cerebellum lacking the 65,000 mol. wt isoform. Neuroscience 93: 1475-1482. (Pubitemid 29397576)
55. Buddhala C, Hsu CC, Wu JY (2009) A novel mechanism for GABA synthesis and packaging into synaptic vesicles. Neurochem Int 55: 9-12.
56. Schousboe A, Waagepetersen HS (2006) Glial modulation of GABAergic and glutamat ergic neurotransmission. Curr Top Med Chem 6: 929-934. (Pubitemid 43796952)
57. Nguyen MV, Du F, Felice CA, Shan X, Nigam A, et al. (2012) MeCP2 is critical for maintaining mature neuronal networks and global brain anatomy during late stages of postnatal brain development and in the mature adult brain. J Neurosci 32: 10021-10034.
58. Ricciardi S, Boggio EM, Grosso S, Lonetti G, Forlani G, et al. (2011) Reduced AKT/mTOR signaling and protein synthesis dysregulation in a Rett syndrome animal model. Hum Mol Genet 20: 1182-1196.
59. Klausberger T, Somogyi P (2008) Neuronal diversity and temporal dynamics: the unity of hippocampal circuit operations. Science 321: 53-57. (Pubitemid 351956237)
60. Kullmann DM (2011) Interneuron networks in the hippocampus. Curr Opin Neurobiol 21: 709-716.
61. Erlander MG, Tillakaratne NJ, Feldblum S, Patel N, Tobin AJ (1991) Two genes encode distinct glutamate decarboxylases. Neuron 7: 91-100.
62. Esclapez M, Tillakaratne NJ, Kaufman DL, Tobin AJ, Houser CR (1994) Comparative localization of two forms of glutamic acid decarboxylase and their mRNAs in rat brain supports the concept of functional differences between the forms. J Neurosci 14: 1834-1855. (Pubitemid 24080030)
63. Sloviter RS, Dichter MA, Rachinsky TL, Dean E, Goodman JH, et al. (1996) Basal expression and induction of glutamate decarboxylase and GABA in excitatory granule cells of the rat and monkey hippocampal dentate gyrus. J Comp Neurol 373: 593-618. (Pubitemid 26336949)
64. Jin H, Wu H, Osterhaus G, Wei J, Davis K, et al. (2003) Demonstration of functional coupling between gamma -aminobutyric acid (GABA) synthesis and vesicular GABA transport into synaptic vesicles. Proc Natl Acad Sci U S A 100: 4293-4298. (Pubitemid 36418196)
65. Mathews GC, Diamond JS (2003) Neuronal glutamate uptake Contributes to GABA synthesis and inhibitory synaptic strength. J Neurosci 23: 2040-2048. (Pubitemid 36368891)
66. Danbolt NC (2001) Glutamate uptake. Prog Neurobiol 65: 1-105.
67. Lee M, McGeer EG, McGeer PL (2011) Mechanisms of GABA release from human astrocytes. Glia 59: 1600-1611.
68. Sherif F, Eriksson L, Oreland L (1991) GABA-transaminase activity in rat and human brain: regional, age and sex-related differences. J Neural Transm Gen Sect 84: 95-102.
69. Chatton JY, Pellerin L, Magistretti PJ (2003) GABA uptake into astrocytes is not associated with significant metabolic cost: implications for brain imaging of inhibitory transmission. Proc Natl Acad Sci U S A 100: 12456-12461. (Pubitemid 37271581)
70. Lioy DT, Garg SK, Monaghan CE, Raber J, Foust KD, et al. (2011) A role for glia in the progression of Rett's syndrome. Nature 475: 497-500.
71. Okabe Y, Takahashi T, Mitsumasu C, Kosai K, Tanaka E, et al. (2012) Alterations of gene expression and glutamate clearance in astrocytes derived from an MeCP2-null mouse model of Rett syndrome. PLoS One 7: e35354.
72. Maezawa I, Jin LW (2010) Rett syndrome microglia damage dendrites and synapses by the elevated release of glutamate. J Neurosci 30: 5346-5356.
73. Madsen KK, White HS, Schousboe A (2010) Neuronal and non-neuronal GABA transporters as targets for antiepileptic drugs. Pharmacol Ther 125: 394-401.